Text Size

Identifying the Gaps in the Diagnosis and Management of Hepatitis C

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2009 by Henry Ford Health System.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Henry Ford Health System
ClinicalTrials.gov Identifier:
NCT00976781
First received: September 10, 2009
Last updated: September 11, 2009
Last verified: September 2009
History of Changes
  Purpose

The purpose of this study is to identify the gaps in diagnosing and managing hepatitis C infected patients so that interventions can be targeted to address these problem areas in order to optimize care of these patients.


Condition
Hepatitis C

Study Type: Observational
Study Design: Time Perspective: Retrospective
Official Title: Identifying the Gaps in the Diagnosis and Management of Hepatitis C

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Henry Ford Health System:

Primary Outcome Measures:
  • This is a retrospective observational study. The outcome measure would be the number of patients who are actually followed and treated for hepatitis C after they have been diagnosed [ Time Frame: One year ] [ Designated as safety issue: No ]

Estimated Enrollment: 200
Study Start Date: August 2008
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Patients diagnosed with hepatitis C

Criteria

Inclusion Criteria:

  • Every patient diagnosed with hepatitis C

Exclusion Criteria:

  • Patients younger than 18 years old
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00976781

Locations
United States, Michigan
Henry Ford Hospital
Detroit, Michigan, United States, 48202
Hnery Ford Hospital
Detroit, Michigan, United States, 48202
Sponsors and Collaborators
Henry Ford Health System
  More Information

No publications provided

Responsible Party: Maria C Segovia, Henry Ford Health System
ClinicalTrials.gov Identifier: NCT00976781     History of Changes
Other Study ID Numbers: IRB no. 4775
Study First Received: September 10, 2009
Last Updated: September 11, 2009
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Hepatitis
Hepatitis A
Hepatitis C
Liver Diseases
Digestive System Diseases
Hepatitis, Viral, Human
 Virus Diseases
Enterovirus Infections
Picornaviridae Infections
RNA Virus Infections
Flaviviridae Infections

ClinicalTrials.gov processed this record on May 16, 2013